Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Cancer Immunology Research|March 12, 2016
Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 TherapyAllison R Greenplate, Douglas B Johnson, Mikael Roussel, et al.Journal of Leukocyte Biology|April 13, 2017
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrowMikael Roussel, P Brent Ferrell, Allison R Greenplate, et al.Experimental Hematology|February 19, 2026
TET2 loss enhances early response to inflammation in primitive and committed myeloid cellsMatthew T Jenkins, Rebecca Dubin, Kirsten M Dickerson, et al.Circulation Research|January 30, 2025
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic PotentialZachary A Kohutek, Heather L Caslin, Daniel J Fehrenbach, et al.The Oncologist|March 2, 2019
Hematologic Complications of Immune Checkpoint InhibitorsElizabeth J Davis, Joe-Elie Salem, Arissa Young, et al.Experimental Hematology|January 24, 2025
TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiationMatthew T Jenkins, Yunli E Chu, Alana M Franceski, et al.Blood Cancer Discovery|May 6, 2022
Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid LeukemiaTiffany Guess, Chad R Potts, Pawan Bhat, et al.Eclinicalmedicine|June 17, 2025
Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control studyJames Brogan, Ashwin Kishtagari, Robert W Corty, et al.Blood|November 20, 2024
Methylation sequencing enhances interpretation of clonal hematopoiesis dynamicsAlyssa C Parker, Joseph C Van Amburg, J Brett Heimlich, et al.Cell Reports|July 17, 2025
Integration of phospho-signaling and transcriptomics in single cells reveals distinct Th17 cell fatesSeth D Fortmann, Awalpreet S Chadha, Blake F Frey, et al.Pageof 5